
A new angiogenesis inhibitor targeting multiple tyrosine kinases offers new hope for treating tumors
Guest
Latest posts by Guest (see all)
- Microbial forensics: It’s not just fingerprints that can be left behind - 12th May 2015
- How can ‘conservation genomics’ help the recovery of the most endangered species? - 12th December 2014
- Acetate helps hypoxic cancer cells get fat - 11th December 2014
A guest blog from co-Editor-in-Chief of Vascular Cell, Jan Kitajewski, in which he discusses the potential of using the newly developed lenvatinib as… Read more »